Bradley Foster & Sargent Inc. CT Trims Stake in CVS Health Co. (NYSE:CVS)

Bradley Foster & Sargent Inc. CT lessened its holdings in CVS Health Co. (NYSE:CVS) by 7.6% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,376 shares of the pharmacy operator’s stock after selling 1,850 shares during the period. Bradley Foster & Sargent Inc. CT’s holdings in CVS Health were worth $1,004,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CVS. Compass Planning Associates Inc purchased a new position in shares of CVS Health during the fourth quarter worth about $37,000. Cromwell Holdings LLC bought a new stake in CVS Health during the fourth quarter valued at approximately $117,000. Handelsbanken Fonder AB grew its stake in CVS Health by 3.6% in the 4th quarter. Handelsbanken Fonder AB now owns 603,225 shares of the pharmacy operator’s stock worth $27,079,000 after buying an additional 20,955 shares in the last quarter. Corps Capital Advisors LLC bought a new position in shares of CVS Health in the 4th quarter worth $239,000. Finally, Financial Perspectives Inc raised its position in shares of CVS Health by 137.5% during the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator’s stock valued at $36,000 after buying an additional 466 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CVS. Truist Financial increased their target price on CVS Health from $60.00 to $76.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective on the stock in a research report on Tuesday, December 3rd. JPMorgan Chase & Co. boosted their target price on CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 18th. Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Finally, Royal Bank of Canada cut their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $70.00.

Insider Buying and Selling

In other CVS Health news, Director Michael F. Mahoney bought 30,000 shares of the stock in a transaction dated Tuesday, February 18th. The stock was purchased at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.24% of the stock is currently owned by insiders.

CVS Health Price Performance

Shares of CVS Health stock opened at $63.42 on Friday. The business has a 50 day moving average of $52.39 and a 200 day moving average of $56.22. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The company has a market cap of $79.95 billion, a PE ratio of 17.33, a P/E/G ratio of 0.98 and a beta of 0.61. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.19%. CVS Health’s dividend payout ratio (DPR) is currently 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.